BioNTech SE (BNTX) Other Accumulated Expenses (2018 - 2021)

BioNTech SE (BNTX) has 4 years of Other Accumulated Expenses data on file, last reported at $1.1 million in Q1 2021.

• For the quarter ending Q1 2021, Other Accumulated Expenses changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2021 stood at $1.1 million (changed N/A YoY), and the FY2020 full-year result was $1.0 million, up 20.41% from the prior year.
• Other Accumulated Expenses grew to $1.1 million in Q1 2021, from $1.1 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $13.7 million in Q3 2019 to a low of $843448.4 in Q4 2019.
• A 4-year average of $4.7 million and a median of $1.1 million in 2021 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses sank 87.95% in 2019 and advanced 27.22% in 2020, its largest moves.
• Tracing BNTX's Other Accumulated Expenses over 4 years: stood at $7.0 million in 2018, then plunged by 87.95% to $843448.4 in 2019, then climbed by 27.22% to $1.1 million in 2020, then advanced by 1.17% to $1.1 million in 2021.
• Business Quant data shows BNTX's Other Accumulated Expenses at $1.1 million in Q1 2021, $1.1 million in Q4 2020, and $843448.4 in Q4 2019.